Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary K Wloch

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Immunological Methods|March 9, 2007
Novel microneutralization assay for HCMV using automated data collection and analysisAnna Maria Abai, Larry R Smith, Mary K Wloch
Vaccines|September 8, 2015
Clinical Development of a Cytomegalovirus DNA Vaccine: From Product Concept to Pivotal Phase 3 TrialLarry R Smith, Mary K Wloch, Jennifer A Chaplin, et al.
Vaccine|January 27, 2009
A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain)Mark A Jacobson, Stuart P Adler, Elizabeth Sinclair, et al.
Veterinary Immunology and Immunopathology|August 21, 2007
A DNA vaccine against dolphin morbillivirus is immunogenic in bottlenose dolphinsKerrie Vaughan, Jason Del Crew, Gary Hermanson, et al.
Human Vaccines & Immunotherapeutics|August 28, 2012
Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirusJukka Hartikka, Vesselina Bozoukova, Jane Morrow, et al.
The Lancet. Infectious Diseases|January 13, 2012
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trialMohamed A Kharfan-Dabaja, Michael Boeckh, Marissa B Wilck, et al.
The Journal of Infectious Diseases|May 1, 2008
Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjectsMary K Wloch, Larry R Smith, Souphaphone Boutsaboualoy, et al.
Vaccine|February 2, 2010
Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutininLarry R Smith, Mary K Wloch, Ming Ye, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Immunological Methods|March 9, 2007
Novel microneutralization assay for HCMV using automated data collection and analysisAnna Maria Abai, Larry R Smith, Mary K Wloch
Vaccines|September 8, 2015
Clinical Development of a Cytomegalovirus DNA Vaccine: From Product Concept to Pivotal Phase 3 TrialLarry R Smith, Mary K Wloch, Jennifer A Chaplin, et al.
Vaccine|January 27, 2009
A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain)Mark A Jacobson, Stuart P Adler, Elizabeth Sinclair, et al.
Veterinary Immunology and Immunopathology|August 21, 2007
A DNA vaccine against dolphin morbillivirus is immunogenic in bottlenose dolphinsKerrie Vaughan, Jason Del Crew, Gary Hermanson, et al.
Human Vaccines & Immunotherapeutics|August 28, 2012
Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirusJukka Hartikka, Vesselina Bozoukova, Jane Morrow, et al.
The Lancet. Infectious Diseases|January 13, 2012
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trialMohamed A Kharfan-Dabaja, Michael Boeckh, Marissa B Wilck, et al.
The Journal of Infectious Diseases|May 1, 2008
Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjectsMary K Wloch, Larry R Smith, Souphaphone Boutsaboualoy, et al.
Vaccine|February 2, 2010
Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutininLarry R Smith, Mary K Wloch, Ming Ye, et al.
Pageof 1